Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price. With potentially many more companies in the medical marijuana IPO pipeline, the entire income statement, including the bottom line, will need to be considered by investors.
- Dan Bilzerian: My Plans to Conquer Marijuana Industry
- Hundreds of Entrepreneurs Have Applied for Arkansas Medical Cannabis Licenses
- Marijuana Consumers Aren’t Hard-core Partiers, They Just Want to Sleep
- This Is Why Nevada Has Summoned the Gaming Policy Committee to Talk Cannabis
- Judge Dismisses Lawsuit Challenging Ban of Medical Cannabis in Kentucky
On Sept. 18, 2017, at 4:30 p.m. CT, the Natural State closed the application window for cultivators and distributors seeking Arkansas medical cannabis licenses. The Department of Finance and Administration received a total of 322 applications, with roughly 200 coming in on the last day to apply.
The ongoing drama over who can distribute recreational marijuana in the state of Nevada is now heading before the Nevada Supreme Court.
On Sept. 18, 2017, the Louisiana State University Agricultural Center announced that it had finalized its LSU medical marijuana contract with GB Sciences Louisiana, a subsidiary of GB Sciences (OTCQB:GBLX).